miR-142-3p regulates autophagy by targeting ATG16L1 in thymic-derived regulatory T cell (tTreg)

Cell Death and Disease - Tập 9 Số 3
Yunjie Lu1, Ji Gao1, Shaopeng Zhang1, Jian Gu1, Hao Lu1, Yongxiang Xia1, Qin Zhu1, Xiaofeng Qian1, Feng Zhang1, Chuanyong Zhang1, Hongbing Shen1, Keli L. Hippen2, Bruce R. Blazar2, Ling Lü1, Xuehao Wang1
1Liver Transplantation Center, First Affiliated Hospital, Nanjing Medical University, No. 300 Guangzhou Road, Jiangsu Province, Nanjing, 210029, China
2Department of Pediatrics, University of Minnesota Cancer Center, Minneapolis, MN, 55455, USA

Tóm tắt

AbstractThymic-derived regulatory T cell (tTreg) clinical trials show therapeutic promise in the prevention of acute graft-versus-host disease (GVHD) in allogeneic hematopoietic stem cell transplantation patients. However, strategies are needed to improve tTreg proliferative ability and survival as a means to improve tTreg therapy and reduce the requirement for producing large numbers of Treg cells for adoptive tTreg transfer. Autophagy is a self-degradative process for cytosolic components, which is involved in cells death, differentiation, lymphocyte homeostasis, and tTreg function. Studies have shown that mice with tTreg cells that have a disrupted autophagy process have defective tTreg cell generation and function, resulting in autoimmune disease and failed GVHD prevention by adoptively transferred tTreg cells. We found the attenuated autophagy status during ex vivo expansion, which leads us to determine whether tTreg cell survival could be augmented by miR-142-3p, the miRNA which is highly expressed in tTreg cells and potentially targets autophagy-related protein (ATG)-1, ATG16L1. We demonstrate that miR-142-3p downregulates ATG16L1 mRNA and production of ATG16L1, that has been linked to autoimmune diseases. Conversely, miR-142-3p knock-down improved tTreg cell expansion, survival and function in vitro and vivo. In aggregate, these studies provide a new approach that uses miR-142-3p knockdown to increase tTreg cell efficacy by increasing ATG16L1 mRNA and protein and the autophagy process.

Từ khóa


Tài liệu tham khảo

Tang, Q. & Vincenti, F. Transplant trials with Tregs: perils and promises. J. Clin. Invest. 127, 2505–2512 (2017).

Bluestone, J. A. & Tang, Q. Immunotherapy: making the case for precision medicine. Sci. Transl. Med. 7, 280ed3 (2015).

Bluestone, J. A. et al. Type 1 diabetes immunotherapy using polyclonal regulatory T cells. Sci. Transl. Med. 7, 315ra189 (2015).

Wang, F., Li, B., Schall, N., Wilhelm, M. & Muller, S. Assessing autophagy in mouse models and patients with systemic autoimmune diseases. Cells 6, 16 (2017).

Arnold, J. et al. Autophagy is dispensable for B-cell development but essential for humoral autoimmune responses. Cell Death Differ. 23, 853–864 (2016).

Wang, F. & Muller, S. Manipulating autophagic processes in autoimmune diseases: a special focus on modulating chaperone-mediated autophagy, an emerging therapeutic target. Front. Immunol. 6, 252 (2015).

Botbol, Y., Guerrero-Ros, I. & Macian, F. Key roles of autophagy in regulating T-cell function. Eur. J. Immunol. 46, 1326–1334 (2016).

Bizargity, P. & Schroppel, B. Autophagy: basic principles and relevance to transplant immunity. Am. J. Transplant. 14, 1731–1739 (2014).

McLeod, I. X., Jia, W. & He, Y. W. The contribution of autophagy to lymphocyte survival and homeostasis. Immunol. Rev. 249, 195–204 (2012).

Mercer, C. A., Kaliappan, A. & Dennis, P. B. A novel, human Atg13 binding protein, Atg101, interacts with ULK1 and is essential for macroautophagy. Autophagy 5, 649–662 (2009).

Murthy, A. et al. A Crohn’s disease variant in Atg16l1 enhances its degradation by caspase 3. Nature 506, 456–462 (2014).

Lassen, K. G. et al. Atg16L1 T300A variant decreases selective autophagy resulting in altered cytokine signaling and decreased antibacterial defense. Proc. Natl Acad. Sci. USA 111, 7741–7746 (2014).

Le Texier, L. et al. Autophagy-dependent regulatory T cells are critical for the control of graft-versus-host disease. JCI Insight 1, e86850 (2016).

Ambros, V. The functions of animal microRNAs. Nature 431, 350–355 (2004).

Bartel, D. P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281–297 (2004).

Ding, S. et al. Decreased microRNA-142-3p/5p expression causes CD4+ T cell activation and B cell hyperstimulation in systemic lupus erythematosus. Arthritis Rheum. 64, 2953–2963 (2012).

Lu, Y. et al. miR-146b antagomir-treated human Tregs acquire increased GVHD inhibitory potency. Blood 128, 1424–1435 (2016).

Abdulrahman, B. A. et al. The celecoxib derivatives AR-12 and AR-14 induce autophagy and clear prion-infected cells from prions. Sci. Rep. 7, 17565 (2017).

Hippen, K. L. et al. Umbilical cord blood regulatory T-cell expansion and functional effects of tumor necrosis factor receptor family members OX40 and 4-1BB expressed on artificial antigen-presenting cells. Blood 112, 2847–2857 (2008).

Pua, H. H., Dzhagalov, I., Chuck, M., Mizushima, N. & He, Y. W. A critical role for the autophagy gene Atg5 in T cell survival and proliferation. J. Exp. Med. 204, 25–31 (2007).

Stephenson, L. M. et al. Identification of Atg5-dependent transcriptional changes and increases in mitochondrial mass in Atg5-deficient T lymphocytes. Autophagy 5, 625–635 (2009).

Kabat, A. M. et al. The autophagy gene Atg16l1 differentially regulates Treg and TH2 cells to control intestinal inflammation. Elife 5, e12444 (2016).

Pua, H. H., Guo, J., Komatsu, M. & He, Y. W. Autophagy is essential for mitochondrial clearance in mature T lymphocytes. J. Immunol. 182, 4046–4055 (2009).

Kovacs, J. R. et al. Autophagy promotes T-cell survival through degradation of proteins of the cell death machinery. Cell Death Differ. 19, 144–152 (2012).

Schaefer, J. S. et al. MicroRNA signatures differentiate Crohn’s disease from ulcerative colitis. BMC Immunol. 16, 5 (2015).

Tischner, D. et al. Defective cell death signalling along the Bcl-2 regulated apoptosis pathway compromises Treg cell development and limits their functionality in mice. J. Autoimmun. 38, 59–69 (2012).

Haque, R., Lei, F., Xiong, X., Wu, Y. & Song, J. FoxP3 and Bcl-xL cooperatively promote regulatory T cell persistence and prevention of arthritis development. Arthritis Res. Ther. 12, R66 (2010).

Pierson, W. et al. Antiapoptotic Mcl-1 is critical for the survival and niche-filling capacity of Foxp3(+) regulatory T cells. Nat. Immunol. 14, 959–965 (2013).

Liu H, Yang H, Chen X, Lu Y, Zhang Z, Wang J, Zhang M, Xue L, Xue F, Liu G. Cellular metabolism modulation in T lymphocyte immunity. Immunology 2014. Accepted Article.

Bai, L. Y., Chiu, C. F., Chiu, S. J., Chu, P. C. & Weng, J. R. FTY720 induces autophagy-associated apoptosis in human oral squamous carcinoma cells, in part, through a reactive oxygen species/Mcl-1-dependent mechanism. Sci. Rep. 7, 5600 (2017).

Cianfanelli, V. et al. AMBRA1 links autophagy to cell proliferation and tumorigenesis by promoting c-Myc dephosphorylation and degradation. Nat. Cell Biol. 17, 706 (2015).

Chu, J. Q. et al. Toxoplasma gondii induces autophagy and apoptosis in human umbilical cord mesenchymal stem cells via downregulation of Mcl-1. Cell Cycle 16, 477–486 (2017).

Grass, J. A. et al. Prevention of transfusion-associated graft-versus-host disease by photochemical treatment. Blood 93, 3140–3147 (1999).

Zhao, J. et al. Selective depletion of CD4+CD25+Foxp3+ regulatory T cells by low-dose cyclophosphamide is explained by reduced intracellular ATP levels. Cancer Res 70, 4850–4858 (2010).

Huang, B. et al. miR-142-3p restricts cAMP production in CD4+CD25- T cells and CD4+CD25+ TREG cells by targeting AC9 mRNA. EMBO Rep. 10, 180–185 (2009).

Carrington, J. C. & Ambros, V. Role of microRNAs in plant and animal development. Science 301, 336–338 (2003).

Holmstrom, K., Pedersen, A. E. & Gad, M. Analysis of miR-146a and miR-142-3p as potential markers of freshly isolated or in vitro-expanded human Treg cells. Scand. J. Immunol. 85, 113–121 (2017).

Bissels, U. et al. Combined characterization of microRNA and mRNA profiles delineates early differentiation pathways of CD133+ and CD34+ hematopoietic stem and progenitor cells. Stem Cells 29, 847–857 (2011).

Dou, L. et al. MicroRNA-142-3p inhibits cell proliferation in human acute lymphoblastic leukemia by targeting the MLL-AF4 oncogene. Mol. Biol. Rep. 40, 6811–6819 (2013).

Zhang, Y., Liu, Y. & Xu, X. Upregulation of miR-142-3p improves drug sensitivity of acute myelogenous leukemia through reducing P-glycoprotein and repressing autophagy by targeting HMGB1. Transl. Oncol. 10, 410–418 (2017).

Lv, M. et al. An oncogenic role of miR-142-3p in human T-cell acute lymphoblastic leukemia (T-ALL) by targeting glucocorticoid receptor-alpha and cAMP/PKA pathways. Leukemia 26, 769–777 (2012).

Wang, Y., Ouyang, M., Wang, Q. & Jian, Z. MicroRNA-142-3p inhibits hypoxia/reoxygenationinduced apoptosis and fibrosis of cardiomyocytes by targeting high mobility group box 1. Int. J. Mol. Med. 38, 1377–1386 (2016).

Guo, F. et al. microRNA-142-3p inhibits apoptosis and inflammation induced by bleomycin through down-regulation of Cox-2 in MLE-12 cells. Braz. J. Med. Biol. Res. 50, e5974 (2017).

Shu, X. et al. Potential role of autophagy in Tcell survival in polymyositis and dermatomyositis. Mol. Med. Rep. 16, 1180–1188 (2017).

Kabat, A. M., Pott, J. & Maloy, K. J. The mucosal immune system and its regulation by autophagy. Front. Immunol. 7, 240 (2016).

Alissafi, T. et al. Tregs restrain dendritic cell autophagy to ameliorate autoimmunity. J. Clin. Invest. 127, 2789–2804 (2017).

Keller, C. W. & Lunemann, J. D. Autophagy and autophagy-related proteins in CNS autoimmunity. Front. Immunol. 8, 165 (2017).

Simon, H. U., Friis, R., Tait, S. W. & Ryan, K. M. Retrograde signaling from autophagy modulates stress responses. Sci. Signal 10, eaag2791 (2017).

Wei, J. et al. Autophagy enforces functional integrity of regulatory T cells by coupling environmental cues and metabolic homeostasis. Nat. Immunol. 17, 277–285 (2016).

Filippini, P. & Rutella, S. Recent advances on cellular therapies and immune modulators for graft-versus-host disease. Expert Rev. Clin. Immunol. 10, 1357–1374 (2014).

Lee, E. S. et al. Adoptive transfer of Treg cells combined with mesenchymal stem cells facilitates repopulation of endogenous Treg cells in a murine acute GVHD model. PLoS ONE 10, e0138846 (2015).